These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17081212)

  • 1. Newly detected atrial fibrillation following dual chamber pacemaker implantation.
    Cheung JW; Keating RJ; Stein KM; Markowitz SM; Iwai S; Shah BK; Lerman BB; Mittal S
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1323-8. PubMed ID: 17081212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation.
    Mittal S; Stein K; Gilliam FR; Kraus SM; Meyer TE; Christman SA
    Am J Cardiol; 2008 Aug; 102(4):450-3. PubMed ID: 18678304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
    Hohnloser SH; Capucci A; Fain E; Gold MR; van Gelder IC; Healey J; Israel CW; Lau CP; Morillo C; Connolly SJ;
    Am Heart J; 2006 Sep; 152(3):442-7. PubMed ID: 16923410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial.
    Orlov MV; Ghali JK; Araghi-Niknam M; Sherfesee L; Sahr D; Hettrick DA;
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):404-11. PubMed ID: 17367361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of structural heart disease on characteristics of atrial fibrillation recurrence in patients with dual-chamber pacemakers.
    Reiter MJ; Harsch M; Lung TH; Munneke D; Kim MH; Shalaby A;
    J Electrocardiol; 2009; 42(2):128-35. PubMed ID: 18976775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial.
    Tsai CT; Lai LP; Hwang JJ; Wang YC; Chiang FT; Lin JL
    Am Heart J; 2008 Jul; 156(1):65-70. PubMed ID: 18585498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation.
    Chen L; Hodge D; Jahangir A; Ozcan C; Trusty J; Friedman P; Rea R; Bradley D; Brady P; Hammill S; Hayes D; Shen WK
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):19-27. PubMed ID: 17971146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-chamber pacemakers as long-term telemetry devices: ready for prime-time in diagnosing unsuspected atrial fibrillation?
    Anderson JL
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1329-31. PubMed ID: 17034408
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Glotzer TV; Silverman R; Yee R; Lee KL; Lamas GA;
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):153-60. PubMed ID: 15028043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinus and paced P wave duration and dispersion as predictors of atrial fibrillation after pacemaker implantation in patients with isolated sick sinus syndrome.
    Kristensen L; Nielsen JC; Mortensen PT; Christensen PD; Vesterlund T; Pedersen AK; Andersen HR
    Pacing Clin Electrophysiol; 2004 May; 27(5):606-14. PubMed ID: 15125716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial fibrillation before and after pacemaker implantation (WI and DDD) in patients with complete atrioventricular block].
    Matusik P; Woznica N; Lelakowsk J
    Pol Merkur Lekarski; 2010 May; 28(167):345-9. PubMed ID: 20568394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single chamber atrial pacing: a realistic option in sinus node disease: a long-term follow-up study of 213 patients.
    Höijer CJ; Höglund P; Schüller H; Brandt J
    Pacing Clin Electrophysiol; 2007 Jun; 30(6):740-7. PubMed ID: 17547606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables.
    Quirino G; Giammaria M; Corbucci G; Pistelli P; Turri E; Mazza A; Perucca A; Checchinato C; Dalmasso M; Barold SS
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):91-8. PubMed ID: 19140918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E; Saba S
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: results of a randomized controlled study.
    Hermida JS; Kubala M; Lescure FX; Delonca J; Clerc J; Otmani A; Jarry G; Rey JL
    Am Heart J; 2004 Aug; 148(2):312-7. PubMed ID: 15309002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and effectiveness of dual chamber pacing in patients over 80 years of age with previous episodes of paroxysmal atrial fibrillation].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Sparacino L; Antonini-Canterin F; Burelli C; Huang G; Nicolosi GL
    Ital Heart J Suppl; 2002 Oct; 3(10):1027-33. PubMed ID: 12478829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.